نتایج جستجو برای: ii bcl2

تعداد نتایج: 584067  

Journal: :Cancer research 1997
Y Liu L Naumovski P Hanawalt

We investigated the effect of the BCL2 overexpression on nucleotide excision repair (NER) and DNA replication in UV-irradiated HL60 cells. Forty-eight h after 10 J/m2 irradiation, only 4% of the cyclobutane pyrimidine dimers were removed in the BCL2-overexpressing cells, in contrast to 38% removal in control cells. However, the repair of 6-4 pyrimidine pyrimidone photoproducts was not affected ...

Journal: :The EMBO journal 2009
Francesca Mancini Giusy Di Conza Marsha Pellegrino Cinzia Rinaldo Andrea Prodosmo Simona Giglio Igea D'Agnano Fulvio Florenzano Lara Felicioni Fiamma Buttitta Antonio Marchetti Ada Sacchi Alfredo Pontecorvi Silvia Soddu Fabiola Moretti

MDM4 is a key regulator of p53, whose biological activities depend on both transcriptional activity and transcription-independent mitochondrial functions. MDM4 binds to p53 and blocks its transcriptional activity; however, the main cytoplasmic localization of MDM4 might also imply a regulation of p53-mitochondrial function. Here, we show that MDM4 stably localizes at the mitochondria, in which ...

Journal: :Molecular cancer therapeutics 2014
Warren Fiskus Sunil Sharma Jun Qi John A Valenta Leasha J Schaub Bhavin Shah Karissa Peth Bryce P Portier Melissa Rodriguez Santhana G T Devaraj Ming Zhan Jianting Sheng Swaminathan P Iyer James E Bradner Kapil N Bhalla

The bromodomain and extra-terminal (BET) protein family members, including BRD4, bind to acetylated lysines on histones and regulate the expression of important oncogenes, for example, c-MYC and BCL2. Here, we demonstrate the sensitizing effects of the histone hyperacetylation-inducing pan-histone deacetylase (HDAC) inhibitor panobinostat on human acute myelogenous leukemia (AML) blast progenit...

2017
Hiwa K. Saaed Matin A. Mahmood Najmaddin Khoshnaw

Background: Apoptosis-related gene expression such as BCL2, and p53 has been suggested in predicting the patient response to chemoor radiotherapy, as well as patient’s survival. Methods: The aim of this study was to determine changes in BCL2 and p53 apoptosis related gene expressions in chronic lymphocytic leukemia (CLL) patients in response to different chemotherapy regimens and number of trea...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Magdalena Klanova Ladislav Andera Jan Brazina Jan Svadlenka Simona Benesova Jan Soukup Dana Prukova Dana Vejmelkova Radek Jaksa Karel Helman Petra Vockova Lucie Lateckova Jan Molinsky Bokang Calvin Lenyeletse Maswabi Mahmudul Alam Roman Kodet Robert Pytlik Marek Trneny Pavel Klener

PURPOSE To investigate the roles of BCL2, MCL1, and BCL-XL in the survival of diffuse large B-cell lymphoma (DLBCL). EXPERIMENTAL DESIGNS Immunohistochemical analysis of 105 primary DLBCL samples, and Western blot analysis of 18 DLBCL cell lines for the expression of BCL2, MCL1, and BCL-XL. Pharmacologic targeting of BCL2, MCL1, and BCL-XL with ABT-199, homoharringtonine (HHT), and ABT-737. A...

2013
Jessica L. Schwartz-Roberts Ayesha N. Shajahan Katherine L. Cook Robert Clarke

In estrogen receptor–positive (ERþ) breast cancer cells, BCL2 overexpression contributes to antiestrogen resistance. Direct targeting of the antiapoptotic BCL2 members with GX15-070 (obatoclax), a BH3-mimetic currently in clinical development, is an attractive strategy to overcome antiestrogen resistance in some breast cancers. Recently, GX15-070 has been shown to induce both apoptosis and auto...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2017
Andrew W Roberts Stephan Stilgenbauer John F Seymour David C S Huang

Venetoclax is the first BCL2 inhibitor to enter routine clinical practice. It is an orally bioavailable small molecule that binds BCL2 very specifically. Acting as a pharmacologic mimic of the proteins that initiate apoptosis (a so-called BH3 mimetic), venetoclax rapidly induces apoptosis in chronic lymphocytic leukemia (CLL) cells, which express high levels of BCL2 and rely on it to maintain t...

Journal: :Journal of hematopathology 2016
Michiel van den Brand Olga Balagué Patricia H J van Cleef Patricia J T A Groenen Konnie M Hebeda Daphne de Jong J Han J M van Krieken

In our consultation practice, it was noted that many cases that were considered to represent follicular lymphoma (FL) without a BCL2 translocation were ultimately classified as nodal marginal zone lymphoma (NMZL). This study set out to define recurrent morphological features of these cases. Thirty-three low-grade B cell lymphomas without a BCL2 rearrangement were studied for recurrent morpholog...

2016
Ksenija Vucicevic Vladimir Jakovljevic Natasa Colovic Natasa Tosic Tatjana Kostic Irena Glumac Sonja Pavlovic Teodora Karan-Djurasevic Milica Colovic

BACKGROUND In chronic lymphocytic leukemia (CLL), in vivo apoptotic resistance of malignant B lymphocytes results, in part, from the intrinsic defects of their apoptotic machinery. These include genetic alterations and aberrant expression of many apoptosis regulators, among which the Bcl2 family members play a central role. AIM The aim of this study was to investigate the association of pro-a...

2015
Tomokazu Murakawa Osamu Yamaguchi Ayako Hashimoto Shungo Hikoso Toshihiro Takeda Takafumi Oka Hiroki Yasui Hiromichi Ueda Yasuhiro Akazawa Hiroyuki Nakayama Manabu Taneike Tomofumi Misaka Shigemiki Omiya Ajay M. Shah Akitsugu Yamamoto Kazuhiko Nishida Yoshinori Ohsumi Koji Okamoto Yasushi Sakata Kinya Otsu

Damaged mitochondria are removed by mitophagy. Although Atg32 is essential for mitophagy in yeast, no Atg32 homologue has been identified in mammalian cells. Here, we show that Bcl-2-like protein 13 (Bcl2-L-13) induces mitochondrial fragmentation and mitophagy in mammalian cells. First, we hypothesized that unidentified mammalian mitophagy receptors would share molecular features of Atg32. By s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید